Atypical inflammatory demyelinating syndromes of the CNS

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001729 · Cited by 4,649

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239

Revised diagnostic criteria for neuromyelitis optica

Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568

The spectrum of neuromyelitis optica

Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Lucchinetti, C., Mandler, R., McGavern, D., Brück, W., Gleich, G., Ransohoff, R., Trebst, C., Weinshenker, B., Wingerchuk, D., Parisi, J., et al. (2002) · Brain : a journal of neurology · doi:10.1093/brain/awf151 · Cited by 1,228

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions

Krupp, L. B., Tardieu, M., Amato, M. P., Banwell, B., Chitnis, T., Dale, R. C., Ghezzi, A., Hintzen, R., Kornberg, A., Pohl, D., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513484547 · Cited by 1,130

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

Filippi, M., Rocca, M. A., Ciccarelli, O., De Stefano, N., Evangelou, N., Kappos, L., Rovira, A., Sastre-Garriga, J., Tintorè, M., Frederiksen, J. L., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00393-2 · Cited by 880

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000101 · Cited by 850

Consensus definitions proposed for pediatric multiple sclerosis and related disorders

Krupp, L., Banwell, B., & Tenembaum, S. N. (2007) · Neurology · doi:10.1212/01.wnl.0000259422.44235.a8 · Cited by 757

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis

Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Brück, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children

Dale, R. C. (2000) · Brain · doi:10.1093/brain/123.12.2407 · Cited by 703

Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression

Pittock, S. J., Weinshenker, B. G., Lucchinetti, C. F., Wingerchuk, D. M., Corboy, J. R., & Lennon, V. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.964 · Cited by 699

MRI characteristics of neuromyelitis optica spectrum disorder: An international update

Kim, H. J., Paul, F., Lana-Peixoto, M. A., Tenembaum, S., Asgari, N., Palace, J., Klawiter, E. C., Sato, D. K., de Seze, J., Wuerfel, J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001367 · Cited by 664

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis

Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., & Itoyama, Y. (2007) · Brain · doi:10.1093/brain/awm047 · Cited by 613

Aquaporin 4 and neuromyelitis optica

Papadopoulos, M. C., & Verkman, A. S. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 608

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study

Kitley, J., Waters, P., Woodhall, M., Leite, M. I., Murchison, A., George, J., Küker, W., Chandratre, S., Vincent, A., & Palace, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5857 · Cited by 597

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

Neuromyelitis Optica Study Group (NEMOS), Trebst, C., Jarius, S., Berthele, A., Paul, F., Schippling, S., Wildemann, B., Borisow, N., Kleiter, I., Aktas, O., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7169-7 · Cited by 595

Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis

Titulaer, M. J., Höftberger, R., Iizuka, T., Leypoldt, F., McCracken, L., Cellucci, T., Benson, L. A., Shu, H., Irioka, T., Hirano, M., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24117 · Cited by 518

Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients

Schwarz, S., Mohr, A., Knauth, M., Wildemann, B., & Storch–Hagenlocher, B. (2001) · Neurology · doi:10.1212/wnl.56.10.1313 · Cited by 511

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

Lucchinetti, C. F., Gavrilova, R. H., Metz, I., Parisi, J. E., Scheithauer, B. W., Weigand, S., Thomsen, K., Mandrekar, J., Altintas, A., Erickson, B. J., et al. (2008) · Brain · doi:10.1093/brain/awn098 · Cited by 493

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

Kleiter, I., Gahlen, A., Borisow, N., Fischer, K., Wernecke, K., Wegner, B., Hellwig, K., Pache, F. C., Ruprecht, K., Havla, J. B., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24554 · Cited by 433

Pathology of Demyelinating Diseases

Popescu, B. F. G., & Lucchinetti, C. F. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132443 · Cited by 426

The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica

Lucchinetti, C. F., Guo, Y. X., Popescu, B. F. G., Fujihara, K., Itoyama, Y., & Misu, T. (2013) · Brain Pathology · doi:10.1111/bpa.12099 · Cited by 422

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

Waters, P. J., Woodhall, M. R., O’Connor, K. C., Reindl, M., Lang, B., Sato, D. K., Juryńczyk, M., Tackley, G., Rocha, J., Takahashi, T., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000089 · Cited by 402

Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study

Pittock, S. J., Lennon, V. A., McKeon, A. B., Mandrekar, J. N., Weinshenker, B. G., Lucchinetti, C. F., O’Toole, O., & Wingerchuk, D. M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70076-0 · Cited by 401

Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis

Ramanathan, S., Prelog, K., Barnes, E. H., Tantsis, E. M., Reddel, S. W., Henderson, A. P., Vucic, S., Gorman, M. P., Benson, L. A., Alper, G., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515593406 · Cited by 384

The spectrum of MOG autoantibody-associated demyelinating diseases

Reindl, M., Pauli, F. D., Rostasy, K. M., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 376

Acute Disseminated Encephalomyelitis

Menge, T., Hemmer, B., Nessler, S., Wiendl, H., Neuhaus, O., Hartung, H.-P., Kieseier, B. C., & Stüve, O. (2005) · Archives of Neurology · doi:10.1001/archneur.62.11.1673 · Cited by 367

Demographic and clinical features of neuromyelitis optica: A review

Pandit, L., Asgari, N., Apiwattanakul, M., Palace, J., Paul, F., Leite, M., Kleiter, I., Chitnis, T., & the GJCF International Clinical Consortium & Biorepository for Neuromyelitis Optica (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515572406 · Cited by 341

Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes

Hinson, S. R., Romero, M. F., Popescu, B. F. G., Lucchinetti, C. F., Fryer, J. P., Wolburg, H., Fallier‐Becker, P., Noell, S., & Lennon, V. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109980108 · Cited by 335

Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein

Baumann, M., Sahin, K., Lechner, C., Hennes, E. M., Schanda, K., Mader, S., Karenfort, M., Selch, C., Häusler, M., Eisenkölbl, A., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308346 · Cited by 313

Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica

Mealy, M. A., Wingerchuk, D. M., Palace, J. A., Greenberg, B. M., & Levy, M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5699 · Cited by 303

Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

Pröbstel, A., Dornmair, K., Bittner, R., Sperl, P., Jenne, D. E., de Magalhaes, S. L. B., Villalobos, A., Breithaupt, C., Weissert, R., Jacob, U., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c0b1 · Cited by 302

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

Höftberger, R., Sepúlveda, M., Armangué, T., Blanco, Y., Rostasy, K. M., Cobo‐Calvo, Á., Olascoaga, J., Ramió‐Torrentà, L., Reindl, M., Benito‐León, J., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514555785 · Cited by 288

Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?

Zamvil, S. S., & Slavin, A. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000062 · Cited by 276

Acute multiple sclerosis (marburg type) is associated with developmentally immature myelin basic protein

Wood, D. D., Moscarello, M. A., Bilbao, J. M., & O'Connors, P. (1996) · Annals of Neurology · doi:10.1002/ana.410400106 · Cited by 266

Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange

Abboud, H., Petrak, A., Mealy, M. A., Sasidharan, S., Siddique, L., & Levy, M. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515581438 · Cited by 252

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

Ringelstein, M., Ayzenberg, I., Harmel, J., Lauenstein, A.-S., Lensch, E., Stögbauer, F., Hellwig, K., Ellrichmann, G., Stettner, M., Chan, A., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0533 · Cited by 242

Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis

Ramanathan, S., Reddel, S., Henderson, A. P. D., Parratt, J. D. E., Barnett, M. H., Gatt, P. N., Merheb, V., Kumaran, R.-Y. A., Pathmanandavel, K., Sinmaz, N., et al. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000040 · Cited by 234

Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis

Stadelmann, C., Ludwin, S. K., Tabira, T., Guseo, A., Lucchinetti, C. F., Leel-Ôssy, L., Ordinario, A. T., Brück, W., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh457 · Cited by 233

Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children

Hacohen, Y., Absoud, M., Deiva, K., Hemingway, C., Nytrova, P., Woodhall, M., Palace, J., Wassmer, E., Tardieu, M., Vincent, A., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000081 · Cited by 230

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution

Matthews, L., Marasco, R., Jenkinson, M., Küker, W., Luppe, S., Leite, M. I., Giorgio, A., De Stefano, N., Robertson, N., Johansen-Berg, H., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182887957 · Cited by 225

The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease

Wingerchuk, D. M., & Weinshenker, B. G. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511431077 · Cited by 224

Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica

Kim, S., Jeong, I. H., Hyun, J., Joung, A., Jo, H.-J., Hwang, S., Yun, S., Joo, J., & Kim, H. J. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1276 · Cited by 209

Myasthenia gravis and neuromyelitis optica spectrum disorder

Leite, M. I., Coutinho, E., Lana–Peixoto, M. A., Apóstolos‐Pereira, S. L., Waters, P. J., Sato, D. K., Melamud, L., Marta, M., Graham, A., Spillane, J. E., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31825644ff · Cited by 209

Beneficial Plasma Exchange Response in Central Nervous System Inflammatory Demyelination

Magaña, S. M. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.34 · Cited by 200

Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis

Young, N. P., Weinshenker, B. G., Parisi, J. E., Scheithauer, B. W., Giannini, C., Roemer, S. F., Thomsen, K. M., Mandrekar, J. N., Erickson, B. J., & Lucchinetti, C. F. (2010) · Brain · doi:10.1093/brain/awp321 · Cited by 186

The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research

Hohlfeld, R., Dornmair, K., Meinl, E., & Wekerle, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00313-0 · Cited by 185

Zur Kenntnis der sogenannten diffusen Sklerose. (Über Encephalitis periaxialis diffusa.)

Schilder, P. (1912) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02901445 · Cited by 184

Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort

Ketelslegers, I. A., van Pelt, D., Bryde, S., Neuteboom, R. F., Catsman‐Berrevoets, C. E., Hamann, D., & Hintzen, R. Q. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514566666 · Cited by 180

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis

Spadaro, M., Gerdes, L. A., Mayer, M. C., Ertl-Wagner, B. B., Laurent, S. A., Krumbholz, M., Breithaupt, C., Högen, T., Straube, A. M., Giese, A., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.164 · Cited by 176

Neuromyelitis optica pathogenesis and aquaporin 4

Graber, D. J., Levy, M., Kerr, D. A., & Wade, W. F. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-22 · Cited by 170

Tumefactive demyelination: an approach to diagnosis and management

Hardy, T. A., & Chataway, J. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304498 · Cited by 164

Distinguishing Tumefactive Demyelinating Lesions from Glioma or Central Nervous System Lymphoma: Added Value of Unenhanced CT Compared with Conventional Contrast-enhanced MR Imaging

Kim, D. S., Na, D. G., Kim, K. H., Kim, J., Kim, E., Yun, B. L., & Chang, K. (2009) · Radiology · doi:10.1148/radiol.2512072071 · Cited by 159

Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica

Rostasy, K. M., Mader, S., Hennes, E. M., Schanda, K., Gredler, V., Guenther, A., Blaschek, A., Korenke, C., Pritsch, M., Pohl, D., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512470310 · Cited by 154

Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients

Huppke, P., Rostasy, K. M., Karenfort, M., Huppke, B., Seidl, R., Leiz, S., Reindl, M., & Gärtner, J. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512466317 · Cited by 151

Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study

Altıntaş, A., Petek, B., Isik, N., Terzi, M., Bölükbaşı, F. H., Tavşanlı, M. E., Saip, S., Boz, C., Aydın, T., Arici-Duz, O., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512438237 · Cited by 151

The pathological spectrum of CNS inflammatory demyelinating diseases

Hu, W., & Lucchinetti, C. F. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0178-z · Cited by 150

The MRI Appearance of Tumefactive Demyelinating Lesions

Given, C. A., Stevens, B. S., & Lee, C. (2004) · American Journal of Roentgenology · doi:10.2214/ajr.182.1.1820195 · Cited by 144

Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging

Pekçevik, Y., Mitchell, C. H., Mealy, M. A., Orman, G., Lee, I. H., Newsome, S. D., Thompson, C. B., Pardo, C. A., Calabresi, P. A., Levy, M., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515591069 · Cited by 143

Metabolite Findings in Tumefactive Demyelinating Lesions Utilizing Short Echo Time Proton Magnetic Resonance Spectroscopy

Kalis, M., Bowen, B. C., & Quencer, R. M. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0669 · Cited by 142

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain

Saadoun, S., Waters, P. J., Owens, G. P., Bennett, J. L., Vincent, A. C., & Papadopoulos, M. C. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-35 · Cited by 141

Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes

Parratt, J. D. E., & Prineas, J. W. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510382324 · Cited by 134

“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis

Yonezu, T., Ito, S., Mori, M., Ogawa, Y., Makino, T., Uzawa, A., & Kuwabara, S. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513495581 · Cited by 129

Baló's concentric sclerosis

Hardy, T. A., & Miller, D. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70052-3 · Cited by 123

Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy

Barnett, M. H., Prineas, J. W., Buckland, M., Parratt, J., & Pollard, J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511421185 · Cited by 122

Acute demyelinating disease. Classification and non-invasive diagnosis

Poser, S., Lüer, W., Bruhn, H., Frahm, J., Brück, Y., & Felgenhauer, K. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb05490.x · Cited by 119

Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease

Lechner, C., Baumann, M., Hennes, E.-M., Schanda, K., Marquard, K., Karenfort, M., Leiz, S., Pohl, D., Venkateswaran, S., Pritsch, M., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311743 · Cited by 117

Prediction of Neuromyelitis Optica Attack Severity by Quantitation of Complement-Mediated Injury to Aquaporin-4–Expressing Cells

Hinson, S. R., McKeon, A. B., Fryer, J. P., Apiwattanakul, M., Lennon, V. A., & Pittock, S. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.188 · Cited by 117

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in ‘pattern II multiple sclerosis’ and brain biopsy findings in a MOG-IgG-positive case

Jarius, S., Metz, I., König, F. B., Ruprecht, K., Reindl, M., Paul, F., Brück, W., & Wildemann, B. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515622986 · Cited by 116

Schilder's Myelinoclastic Diffuse Sclerosis

Poser, C. M., Goutières, F., Carpentier, M., & Alcardi, J. (1986) · PEDIATRICS · doi:10.1542/peds.77.1.107 · Cited by 112

Immune-mediated CNS diseases: A review on nosological classification and clinical features

Zettl, U. K., Stüve, O., & Patejdl, R. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.008 · Cited by 101

Primary Central Nervous System Lymphoma: From Clinical Presentation to Diagnosis

Herrlinger, U., Schabet, M., Bitzer, M., Petersen, D., & Krauseneck, P. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006298201101 · Cited by 99

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: A review of reported findings

for the MAGNIMS network, Seewann, A., Enzinger, C., Filippi, M., Barkhof, F., Rovira, A., Gass, A., Miller, D., Montalban, X., Thompson, A., et al. (2008) · Journal of Neurology · doi:10.1007/s00415-007-0754-x · Cited by 98

Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study

Atzori, M., Battistella, P. A., de Perini, P., Calabrese, M., Fontanin, M., Laverda, A., Suppiej, A., Drigo, P., Grossi, P., Rinaldi, L., et al. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508098562 · Cited by 91

Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome

Koelman, D. L. H., & Mateen, F. J. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7694-7 · Cited by 89

The Magnetic Resonance Imaging Appearance of Monophasic Acute Disseminated Encephalomyelitis

Marin, S. E., & Callen, D. J. A. (2013) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2012.12.005 · Cited by 84

Zur Frage der Encephalitis periaxialis diffusa (sogenannte diffuse Sklerose)

Schilder, P. (1913) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02895263 · Cited by 84

Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis

Wallner-Blazek, M., Rovira, A., Fillipp, M., Rocca, M. A., Miller, D. H., Schmierer, K., Frederiksen, J., Gass, A., Gama, H., Tilbery, C. P., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6918-y · Cited by 84

Fulminant demyelinating encephalomyelitis

Pauli, F. D., Höftberger, R., Reindl, M., Beer, R., Rhomberg, P., Schanda, K., Sato, D. K., Fujihara, K., Lassmann, H., Schmutzhard, E., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000175 · Cited by 83

Malignant monophasic multiple sclerosis or “Marburg's disease"

Mendez, M. F., & Pogacar, S. (1988) · Neurology · doi:10.1212/wnl.38.7.1153 · Cited by 83

Characteristic Neuroimaging in Patients with Tumefactive Demyelinating Lesions Exceeding 30 mm

Kiriyama, T., Kataoka, H., Taoka, T., Tonomura, Y., Terashima, M., Morikawa, M., Tanizawa, E., Kawahara, M., Furiya, Y., Sugie, K., et al. (2010) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2010.00502.x · Cited by 79

Die Encephalitis periaxialis diffusa

Schilder, P. (1924) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf01813381 · Cited by 79

Tumefactive MS lesions under fingolimod

Pilz, G., Harrer, A., Wipfler, P., Oppermann, K., Sellner, J., Fazekas, F., Trinka, E., & Kraus, J. (2013) · Neurology · doi:10.1212/01.wnl.0000435293.34351.11 · Cited by 78

The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases

Garg, N., Reddel, S. W., Miller, D. H., Chataway, J., Riminton, D. S., Barnett, Y., Masters, L., Barnett, M. H., & Hardy, T. A. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309649 · Cited by 76

Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions

Zeid, N. E. A., Pirko, I., Erickson, B. J., Weigand, S. D., Thomsen, K. M., Scheithauer, B. W., Parisi, J. E., Giannini, C., Linbo, L., & Lucchinetti, C. F. (2012) · Neurology · doi:10.1212/wnl.0b013e3182574f66 · Cited by 71

The Origins of Concentric Demyelination: Self-Organization in the Human Brain

Khonsari, R. H., & Calvez, V. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000150 · Cited by 68

Conventional and Advanced Imaging in Neuromyelitis Optica

Barnett, Y., Sutton, I., Ghadiri, M., Masters, L. T., Zivadinov, R., & Barnett, M. H. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3592 · Cited by 66

Neuromyelitis optica and astrocytic damage in its pathogenesis

Fujihara, K. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.02.018 · Cited by 66

Metabolite Findings in Tumefactive Demyelinating Lesions Utilizing Short Echo Time Proton Magnetic Resonance Spectroscopy

Osborn, A. G. (2007) · Yearbook of Diagnostic Radiology · doi:10.1016/s0098-1672(08)70230-3 · Cited by 66

Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis

Bolat, S., Berding, G., Dengler, R., Stangel, M., & Trebst, C. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.060 · Cited by 64

Treatment of Marburg Variant Multiple Sclerosis with Mitoxantrone

Jeffery, D., Lefkowitz, D. S., & Crittenden, J. P. (2004) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2004.tb00217.x · Cited by 63

Utility of Proton MR Spectroscopy for Differentiating Typical and Atypical Primary Central Nervous System Lymphomas from Tumefactive Demyelinating Lesions

Lu, S., Kim, S. J., Kim, H. S., Choi, C. G., Lim, Y., Kim, E. J., Kim, D. Y., & Cho, S. H. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3677 · Cited by 63

Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO

Gelfand, J. M., Cotter, J. A., Klingman, J. G., Huang, E. J., & Cree, B. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000034 · Cited by 60

Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis

Brenton, J. N., & Banwell, B. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0396-0 · Cited by 59

Bright spotty lesions on the spinal cord: an additional MRI indicator of neuromyelitis optica spectrum disorder?

Hyun, J., Kim, S., Jeong, I. H., Lee, S. H., & Kim, H. J. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309761 · Cited by 58

Baló's disease showing benign clinical course and co-existence with multiple sclerosis-like lesions in Chinese

Wang, C., Kun-nan, Z., Wu, X., Huang, G., Xie, X., Qu, X.-H., & Xiong, Y. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507084036 · Cited by 58

Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló’s concentric sclerosis

Hardy, T. A., Tobin, W. O., & Lucchinetti, C. F. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516641776 · Cited by 58

Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions

Popescu, B. F. G., Guo, Y. X., Jentoft, M. E., Parisi, J. E., Lennon, V. A., Pittock, S. J., Weinshenker, B. G., Wingerchuk, D. M., Giannini, C., Metz, I., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001126 · Cited by 53

A Benign Form of Neuromyelitis Optica

Collongues, N. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.127 · Cited by 53

Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations

Jeong, I. H., Kim, S., Hyun, J., Joung, A., Cho, H., & Kim, H. J. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.08.034 · Cited by 52

Astrocytopathy in Baló’s disease

Kira, J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511400475 · Cited by 47

Marburg's Variant of Multiple Sclerosis Correlates with a Less Compact Structure of Myelin Basic Protein

Beniac, D. R., Wood, D. D., Palaniyar, N., Ottensmeyer, F. P., Moscarello, M. A., & Harauz, G. (1999) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.1999.0111 · Cited by 46

Persistence of Immunopathological and Radiological Traits in Multiple Sclerosis

König, F. B., Wildemann, B., Nessler, S., Zhou, D., Hemmer, B., Metz, I., Hartung, H., Kieseier, B. C., & Brück, W. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1527 · Cited by 46

High dose cyclophosphamide treatment in Marburg variant multiple sclerosis

Nozaki, K., & Abou-Fayssal, N. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.05.022 · Cited by 45

Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and 11C-methionine-, 11C-choline-, and 18F-fluorodeoxyglucose-PET

Takenaka, S., Shinoda, J., Asano, Y., Aki, T., Miwa, K., Ito, T., Yokoyama, K., & Iwama, T. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-011-0027-3 · Cited by 45

Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease

Alexopoulos, H., Kampylafka, E. I., Fouka, P., Tatouli, I. P., Akrivou, S., Politis, P. K., Moutsopoulos, H. Μ., Tzioufas, A. G., & Dalakas, M. C. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.10.007 · Cited by 42

Neuromyelitis optica: a positive appraisal of seronegative cases

Bernard‐Valnet, R., Liblau, R., Vukusic, S., & Marignier, R. (2015) · European Journal of Neurology · doi:10.1111/ene.12679 · Cited by 40

Evolution and long term outcome in patients presenting with large demyelinating lesions as their first clinical event

Wattamwar, P. R., Baheti, N., Kesavadas, C., Nair, M., & Radhakrishnan, A. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.06.030 · Cited by 40

Full recovery after acute hemorrhagic leukoencephalitis (Hurst's disease)

Klein, C. J., Wijdicks, E. F. M., & Earnest, F. (2000) · Journal of Neurology · doi:10.1007/s004150070060 · Cited by 38

Tumefactive demyelination: clinical, imaging and follow-up observations in thirty-nine patients

Nagappa, M., Taly, A. B., Sinha, S., Bharath, R. D., Mahadevan, A., Bindu, P. S., Saini, J. S., Prasad, C., & Shankar, S. K. (2012) · Acta Neurologica Scandinavica · doi:10.1111/ane.12071 · Cited by 37

Spinal cord involvement in Balo's concentric sclerosis

Kreft, K. L., Mellema, S., & Hintzen, R. Q. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.030 · Cited by 35

Early and widespread injury of astrocytes in the absence of demyelination in acute haemorrhagic leukoencephalitis

Robinson, C. A., Adiele, R. C., Tham, M., Lucchinetti, C. F., & Popescu, B. F. G. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-52 · Cited by 34

Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study

Siri, A., Dalliere, C. C., Ayrignac, X., Pelletier, J., Audoin, B., Pittion‐Vouyovitch, S., Debouverie, M., Lionnet, C., Viala, F., Sablot, D., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7758-8 · Cited by 34

CADASIL mutation and Balo concentric sclerosis: A link between demyelination and ischemia?

Chitnis, T., & Hollmann, T. J. (2012) · Neurology · doi:10.1212/wnl.0b013e31823fcd3c · Cited by 33

Acute Tumefactive Demyelinating Lesions in a Pediatric Patient With Known Diagnosis of Multiple Sclerosis: Review of the Literature and Treatment Proposal

Dastgir, J., & DiMario, F. J. (2009) · Journal of Child Neurology · doi:10.1177/0883073808324769 · Cited by 33

An Autopsy Case of the Marburg Variant of Multiple Sclerosis (Acute Multiple Sclerosis)

Suzuki, M., Kawasaki, H., Masaki, K., Suzuki, S. O., Terada, T., Tsuchida, T., Tokuyama, T., Kono, S., Komori, T., Baba, S., et al. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.0425 · Cited by 32

A Long-Term Follow-Up Study Using IPMSSG Criteria in Children With CNS Demyelination

Peche, S. S., Alshekhlee, A., Kelly, J., Lenox, J., & Mar, S. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.06.023 · Cited by 32

Anti-Aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló's Concentric Lesions

Masuda, H., Mori, M., Katayama, K., Kikkawa, Y., & Kuwabara, S. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.9330 · Cited by 27

Baló's concentric sclerosis and tumefactive demyelination: A shared immunopathogenesis?

Hardy, T. A., Beadnall, H. N., Sutton, I. J., Mohamed, A., Jonker, B., Buckland, M. E., & Barnett, M. H. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.11.024 · Cited by 23

Fulminant tumefactive multiple sclerosis: Therapeutic implications of histopathology

Haupts, M. R., Schimrigk, S., Brune, N., Chan, A., Ahle, G., Hellwig, K., König, F. B., Schlegel, U. S., Brück, W., & Gold, R. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0883-x · Cited by 22

An Autopsy Case of Schilder’s Variant of Multiple Sclerosis (Schilder’s Disease)

Miyamoto, N., Kagohashi, M., Nishioka, K., Fujishima, K., Kitada, T., Tomita, Y., Mori, K., Maëda, M., Wada, R., Matsumoto, M., et al. (2006) · European Neurology · doi:10.1159/000092785 · Cited by 21

Rituximab for tumefactive inflammatory demyelination: A case report

Fan, X., Mahta, A., Jager, P. L. D., & Kesari, S. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.03.010 · Cited by 20

Tumefactive multiple sclerosis requiring emergency craniotomy: Case report and literature review

Munarriz, P. M., Castaño-León, A. M., Martínez-Pérez, R., Hernández‐Laín, A., Ramos, A., & Lagares, A. (2013) · Neurocirugía · doi:10.1016/j.neucir.2013.02.008 · Cited by 15

Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?

Weinshenker, B. G. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515603801 · Cited by 14

Concentric Sclerosis (Baló's Disease)

Tabira, T. (2009) · doi:10.1002/9781444317008.ch105 · Cited by 5

0842 Myelin-oligodendrocyte glycoprotein antibody as a cause of acute disseminated encephalomyelitis with a neuromyelitis optica-like phenotype in adults

Kitley, J., Woodhall, M. R., Waters, P. J., Leite, M. I., Devenney, E. M., Craig, J. E., Vincent, A. C., & Palace, J. A. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301993.34 · Cited by 3

Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis

Ramanathan, S., Reddel, S., Henderson, A. P. D., Parratt, J. D. E., Barnett, M. H., Gatt, P. N., Merheb, V., Kumaran, R.-Y. A., Pathmanandavel, K., Sinmaz, N., et al. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.08.065 · Cited by 3

Myelin in the Central Nervous System: Structure, Function, and Pathology

Stadelmann, C., Timmler, S., Barrantes‐Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 799

Diagnosis of multiple sclerosis: progress and challenges

Brownlee, W. J., Hardy, T. A., Fazekas, F., & Miller, D. H. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30959-x · Cited by 701

Myelin oligodendrocyte glycoprotein antibodies in neurological disease

Reindl, M., & Waters, P. J. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0112-x · Cited by 646

Microglia in multiple sclerosis: Friend or foe

Guerrero, B. L., & Sicotte, N. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00374 · Cited by 215

Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?

Reindl, M., Jarius, S., Rostasy, K. M., & Berger, T. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000446 · Cited by 100

The Spectrum of Atypical Inflammatory Demyelinating Syndromes of the Central Nervous System

Hardy, T. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_17

Atypical Inflammatory Demyelinating Syndromes of the Central Nervous System

Hardy, T. A. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_17 · Cited by 1

Atypical inflammatory demyelinating lesions and atypical multiple sclerosis

Ayrignac, X., Dalliere, C. C., & Labauge, P. M. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.03.007 · Cited by 25

The Spectrum of Demyelinating Inflammatory Diseases of the Central Nervous System

Brochet, B. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-18464-7_1 · Cited by 1

Advances in Diagnosis and Management of Atypical Demyelinating Diseases

Hutto, S. K., & Cavanagh, J. J. (2024) · Medical Clinics of North America · doi:10.1016/j.mcna.2024.09.011 · Cited by 4